Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 13 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

9Total

Not Applicable (6)

P 2 (1)

P 4 (2)

Trial Status

Completed8

Not Yet Recruiting3

Recruiting1

Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (13)

Showing 13 of 13 trials

NCT04036695Not ApplicableCompletedPrimary

Arrhythmia in Hemodialysis Patients

NCT07598903Not ApplicableNot Yet Recruiting

Pharmacy-based Opportunistic Atrial Fibrillation Screening Integrated With Emergency Services (NUMAPLUS-FA)

NCT05439031Phase 2Recruiting

StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 2

NCT07183059Not ApplicableNot Yet Recruiting

A Single Center Prospective Study in an Estimated 570 Patients Who Underwent Genetic Screening at UZ Brussel in the Context of a Primary Cardiac Arrhythmia. Patients Showing a Variant Class 3,4 or 5 in SCN4A or CLCN1 Will Undergo a Clinical and Electrophysiological Review After IC.

NCT07157670Not Yet Recruiting

Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

NCT04075994Not ApplicableCompleted

Atrial Fibrillation Health Literacy and Information Technology Trial

NCT04117763Phase 4Completed

Effect of Empagliflozin on Ventricular Repolarization.

NCT03045068Phase 4Completed

Platelet Transfusion During Neonatal Open Heart Surgery

NCT04011683Completed

Hypoglycaemia and Cardiac Arrhythmias in Type 1 Diabetes

NCT04351386Completed

Validation Study of the Watch HWA09 and Its Softwares ECG-SW1 and PPG-SW1 for the Detection of Atrial Fibrillation